Page last updated: 2024-09-05

darunavir and Pregnancy

darunavir has been researched along with Pregnancy in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (14.71)29.6817
2010's21 (61.76)24.3611
2020's8 (23.53)2.80

Authors

AuthorsStudies
Brummel, SS; Chadwick, EG; Huo, Y; Jacobson, DL; Jao, J; Kacanek, D; Kahlert, CR; Patel, K; Powis, KM; Seage, GR; Shiau, S; Sultan-Beyer, L; Williams, PL; Yee, LM; Zash, R1
Avettand-Fenoel, V; Brunet-Cartier, C; Bui, E; Canestri, A; Chabrol, A; Chambrin, V; Delmas, S; Frange, P; Le Chenadec, J; Mandelbrot, L; Marchand, L; Morlat, P; Paul, C; Peretti, D; Peytavin, G; Sibiude, J; Simon-Toulza, C; Tubiana, R; Warszawski, J1
Best, BM; Capparelli, EV; Chakhtoura, N; Eke, AC; Kreitchmann, R; Mirochnick, M; Shapiro, DE; Smith, E; Stek, AM; Wang, J1
Acosta, S; Dunk, C; Kala, S; Serghides, L1
Al-Majed, AA; Alsaif, NA; Alzaid, A; Bakheit, AH; Darwish, IA; Herqash, RN1
Best, BM; Burchett, S; Capparelli, EV; Chakhtoura, N; Denson, K; Febo, IL; George, K; Mirochnick, M; Momper, JD; Paul, ME; Rungruengthanakit, K; Scott, GB; Shapiro, DE; Smith, E; Stek, A; Wang, J; Yang, DZ1
Boix, V; Dash, PK1
Chen, L; He, G; Jia, Y; Tian, X; Wang, K; Yao, Y1
Chatelut, E; Delobel, P; Gandia, P; Metsu, D; Toutain, PL1
Buaben, AO; Burger, DM; Colbers, AP; Freriksen, JJM; Greupink, R; Russel, FGM; Schalkwijk, S1
Kashuba, A; Pope, R1
Cetin, I; Dalzero, S; Degli Antoni, A; Floridia, M; Francisci, D; Frisina, V; Liuzzi, G; Maccabruni, A; Masuelli, G; Ravizza, M; Sansone, M; Simonazzi, G; Tamburrini, E; Tassis, B1
Best, BM; Burger, DM; Capparelli, E; Colbers, A; Cressey, TR; Greupink, R; Karlsson, MO; Mirochnick, M; Moltó, J; Russel, FGM; Schalkwijk, S; Ter Heine, R1
Avramovic, G; Else, LJ; Jackson, V; Khoo, SH; Kuan, KB; Lambert, JS; Lawler, M; Le Blanc, D; McDonald, G; Murtagh, R; Patel, A; Redmond, N1
Bicer, C; Brown, K; Crauwels, HM; Osiyemi, O; Zorrilla, C1
Be, G; Chiesi, S; Lanzafame, M; Lattuada, E; Piacentini, D; Rizzardo, S; Tacconelli, E1
Bonora, S; Calcagno, A; D'Avolio, A; Di Perri, G; Ghisetti, V; Marinaro, L; Montrucchio, C; Trentini, L1
Baugh, B; Brown, K; Coate, B; Falcon, R; Kakuda, TN; Mrus, J; Osiyemi, OO; Verboven, P; Wright, R; Yasin, S; Zorrilla, CD1
Afonina, LIu; Voronin, EE1
Brochot, A; Hoetelmans, RM; Kakuda, TN; Tomaka, FL; Van De Casteele, T; Vangeneugden, T1
Belissa, E; Duro, D; Mandelbrot, L; Peytavin, G1
Burger, D; Colbers, A; Giaquinto, C; Gingelmaier, A; Hawkins, D; Ivanovic, J; Kabeya, K; Moltó, J; Sadiq, ST; Taylor, G; Van der Ende, M; Weizsäcker, K1
Best, BM; Burchett, SK; Capparelli, EV; Cressey, TR; Kreitchmann, R; Mirochnick, M; Mofenson, LM; Rungruengthanakit, K; Shapiro, D; Smith, E; Stek, A; Wang, J1
Burger, D; Colbers, A; Greupink, R; Litjens, C; Russel, FG1
Baugh, B; Brown, K; Crauwels, HM; Hillewaert, V; Kakuda, TN; Osiyemi, OO; Ryan, B; Verboven, P; Yasin, S; Zorrilla, C1
Galindo Puerto, MJ1
Cerini, C; Fasan, S; Giacomet, V; Marchetti, G; Meroni, L; Pradella, A; Vanzulli, A; Viganò, A; Zuccotti, GV1
Abusamra, L; Cahn, P; Cesar, C; Fink, V; Gun, A; Krolewiecki, A; Lattner, J; Patterson, P; Sued, O1
Cattaneo, D; Cortinovis, M; Maggiolo, F; Ripamonti, D; Suter, F1
Bollens, D; Castaigne, V; Girard, PM; Meyohas, MC; Morand-Joubert, L; Pacanowski, J; Poirier, JM1
Portilla, J1
De Luca, A; Navarra, P; Pinnetti, C; Ragazzoni, E; Tamburrini, E1
Bellagamba, R; Ivanovic, J; Mazzitelli, L; Narciso, P; Nicastri, E; Signore, F; Tempestilli, M; Tommasi, C; Vallone, C1
Antoniou, T; Bitnun, A; Brophy, J; Jaworsky, D; Loutfy, MR; Samson, L; Thompson, C; Yudin, MH1

Reviews

5 review(s) available for darunavir and Pregnancy

ArticleYear
Darunavir: A comprehensive profile.
    Profiles of drug substances, excipients, and related methodology, 2021, Volume: 46

    Topics: Darunavir; Drug Resistance, Viral; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Pregnancy; United States

2021
Darunavir for use in pregnant women with HIV.
    Expert review of clinical pharmacology, 2017, Volume: 10, Issue:12

    Topics: Animals; Darunavir; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious

2017
[Use of darunavir in HIV-infected women during pregnancy].
    Terapevticheskii arkhiv, 2013, Volume: 85, Issue:11

    Topics: Darunavir; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy; Pregnancy Complications, Infectious; Sulfonamides; Treatment Outcome

2013
Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:10

    Topics: Age Factors; Anti-HIV Agents; Darunavir; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Pregnancy; Sex Factors; Sulfonamides

2014
[Safety and tolerability of etravirine].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27 Suppl 2

    Topics: Animals; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Darunavir; Drug Eruptions; Drug Evaluation, Preclinical; Dyslipidemias; Female; Fetus; Gastrointestinal Diseases; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Sulfonamides

2009

Trials

6 trial(s) available for darunavir and Pregnancy

ArticleYear
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
    The Journal of antimicrobial chemotherapy, 2023, 07-05, Volume: 78, Issue:7

    Topics: Anti-HIV Agents; Darunavir; Female; HIV Infections; Humans; Infant, Newborn; Pregnancy; Ritonavir; Treatment Outcome; Viral Load

2023
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.
    AIDS (London, England), 2021, 07-01, Volume: 35, Issue:8

    Topics: Anti-HIV Agents; Child; Cobicistat; Darunavir; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Placenta; Postpartum Period; Pregnancy; Prospective Studies

2021
Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen.
    HIV medicine, 2019, Volume: 20, Issue:5

    Topics: Adult; Cobicistat; Darunavir; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal Age; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Treatment Outcome

2019
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
    HIV medicine, 2014, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Darunavir; Drug Administration Schedule; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Sulfonamides; Young Adult

2014
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:2

    Topics: Adult; Darunavir; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sulfonamides; Treatment Outcome; Viral Load; Young Adult

2015
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
    HIV medicine, 2016, Volume: 17, Issue:9

    Topics: Adolescent; Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Darunavir; Female; HIV Infections; Humans; Plasma; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Tandem Mass Spectrometry; Young Adult

2016

Other Studies

23 other study(ies) available for darunavir and Pregnancy

ArticleYear
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    The New England journal of medicine, 2022, 09-01, Volume: 387, Issue:9

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cobicistat; Cohort Studies; Darunavir; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Oxazines; Piperazines; Pregnancy; Premature Birth; Pyridones; Quinolones; Raltegravir Potassium; Rilpivirine; Ritonavir; United States

2022
Darunavir Pharmacokinetics With an Increased Dose During Pregnancy.
    Journal of acquired immune deficiency syndromes (1999), 2020, 04-01, Volume: 83, Issue:4

    Topics: Adult; Darunavir; Dose-Response Relationship, Drug; Drug Combinations; Female; HIV; HIV Infections; Humans; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Statistics as Topic; Young Adult

2020
Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.
    Human reproduction (Oxford, England), 2020, 08-01, Volume: 35, Issue:8

    Topics: Animals; Betacoronavirus; Cells, Cultured; Clinical Trials as Topic; Coculture Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Decidua; Disease Models, Animal; Drug Repositioning; Drug Therapy, Combination; Embryo Implantation; Endometrium; Female; HIV Infections; Humans; Lopinavir; Maternal Exposure; Mice; Pandemics; Placentation; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Primary Cell Culture; SARS-CoV-2; Trophoblasts; Vascular Remodeling

2020
Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
    AIDS (London, England), 2021, 07-01, Volume: 35, Issue:8

    Topics: Anti-HIV Agents; Cobicistat; Darunavir; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy

2021
Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database.
    Scientific reports, 2021, 06-14, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Darunavir; Data Mining; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pharmacovigilance; Pregnancy; Pregnancy Complications; United States; United States Food and Drug Administration; Young Adult

2021
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?
    The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9

    Topics: Atazanavir Sulfate; Blood Proteins; Darunavir; Dose-Response Relationship, Drug; Female; Hepatocytes; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy; Protein Binding

2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.
    Clinical pharmacokinetics, 2018, Volume: 57, Issue:6

    Topics: Darunavir; Drug Therapy, Combination; Female; Fetus; HIV Protease Inhibitors; Humans; Maternal-Fetal Exchange; Models, Biological; Placenta; Pregnancy; Ritonavir

2018
Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study.
    The Journal of antimicrobial chemotherapy, 2018, 04-01, Volume: 73, Issue:4

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Cholesterol; Darunavir; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Treatment Outcome; Triglycerides; Viral Load

2018
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling.
    The Journal of antimicrobial chemotherapy, 2019, 05-01, Volume: 74, Issue:5

    Topics: Anti-HIV Agents; Computer Simulation; Darunavir; Dose-Response Relationship, Drug; Female; Gestational Age; HIV Seropositivity; Humans; Models, Theoretical; Population; Pregnancy; Pregnancy Complications, Infectious; Ritonavir

2019
Therapeutic drug monitoring of darunavir/ritonavir in pregnancy.
    Antiviral therapy, 2019, Volume: 24, Issue:3

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Darunavir; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Treatment Outcome; Viral Load; Young Adult

2019
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report.
    Journal of medical case reports, 2019, Jul-23, Volume: 13, Issue:1

    Topics: Darunavir; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Oxazines; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Pyridones; Viral Load; Young Adult

2019
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclohexanes; Darunavir; Female; HIV Infections; Humans; Infant; Infant, Newborn; Maraviroc; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; RNA, Viral; Sulfonamides; Treatment Failure; Triazoles; Viral Load

2013
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Biological Transport; Darunavir; Female; HIV Protease Inhibitors; Humans; Maternal-Fetal Exchange; Placenta; Pregnancy; Sulfonamides

2014
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.
    Journal of acquired immune deficiency syndromes (1999), 2015, Sep-01, Volume: 70, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Chromatography, High Pressure Liquid; Cohort Studies; Darunavir; Female; HIV Infections; Humans; Plasma; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Ritonavir; Sulfonamides; Young Adult

2015
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
    Clinical pharmacokinetics, 2016, Volume: 55, Issue:3

    Topics: Adult; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver; Models, Biological; Pregnancy; Ritonavir; Young Adult

2016
[Darunavir in special situations].
    Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34 Suppl 1

    Topics: Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver; Male; Pregnancy; Pregnancy Complications, Infectious; Ritonavir

2016
Successful rescue therapy with a darunavir/ritonavir and etravirine antiretroviral regimen in a child with vertically acquired multidrug-resistant HIV-1.
    Antiviral therapy, 2008, Volume: 13, Issue:6

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Darunavir; Drug Resistance, Multiple, Viral; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Ritonavir; Sulfonamides; Treatment Outcome; Viral Load

2008
Use of darunavir and enfuvirtide in a pregnant woman.
    International journal of STD & AIDS, 2008, Volume: 19, Issue:12

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Darunavir; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Enfuvirtide; Female; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Peptide Fragments; Pregnancy; Pregnancy Outcome; Sulfonamides; Treatment Outcome; Viral Load

2008
Transplacental passage of ritonavir-boosted darunavir in two pregnant women.
    International journal of STD & AIDS, 2009, Volume: 20, Issue:3

    Topics: Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Sulfonamides

2009
Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient.
    AIDS (London, England), 2009, Sep-10, Volume: 23, Issue:14

    Topics: Darunavir; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Sulfonamides; Treatment Outcome

2009
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.
    Antiviral therapy, 2010, Volume: 15, Issue:1

    Topics: Darunavir; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; RNA, Viral; Sulfonamides; Young Adult

2010
Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety.
    AIDS (London, England), 2010, Apr-24, Volume: 24, Issue:7

    Topics: Adult; CD4 Lymphocyte Count; Darunavir; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Sulfonamides; Treatment Outcome; Viral Load

2010
Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases.
    Antiviral therapy, 2010, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Darunavir; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nitriles; Pregnancy; Pregnancy Complications, Infectious; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Sulfonamides; Treatment Outcome; Young Adult

2010